Similar articles

• Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.

  Ochsenkühn T, Göke B, Sackmann M. Ochsenkühn T, et al. Am J Gastroenterol. 2002 Aug;97(8):2022-5. doi: 10.1111/j.1572-0241.2002.05918.x. Am J Gastroenterol. 2002. PMID: 12190171
• Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.

  Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S. Borrelli O, et al. Dig Liver Dis. 2004 May;36(5):342-7. doi: 10.1016/j.dld.2003.12.014. Dig Liver Dis. 2004. PMID: 15191204 Clinical Trial.
• Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.

  Hlavaty T, Pierik M, Henckaerts L, Ferrante M, Joossens S, van Schuerbeek N, Noman M, Rutgeerts P, Vermeire S. Hlavaty T, et al. Aliment Pharmacol Ther. 2005 Oct 1;22(7):613-26. doi: 10.1111/j.1365-2036.2005.02635.x. Aliment Pharmacol Ther. 2005. PMID: 16181301
• Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.

  Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M. Caprilli R, et al. Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013. Dig Liver Dis. 2005. PMID: 15893279 Review.
• Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.

  Sandborn WJ, Hanauer SB. Sandborn WJ, et al. Am J Gastroenterol. 2002 Dec;97(12):2962-72. doi: 10.1111/j.1572-0241.2002.07093.x. Am J Gastroenterol. 2002. PMID: 12492177 Review.